Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Fahn

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Translation of Oppenheim's 1911 paper on dystoniaChristine Klein, Stanley Fahn
Cold Spring Harbor Perspectives in Medicine|September 22, 2025
Parkinson's Disease, Second EditionSerge Przedborski, Stanley Fahn
The Journal of Neuropsychiatry and Clinical Neurosciences|November 12, 2002
Methylphenidate treats apathy in Parkinson's diseaseAnjan Chatterjee, Stanley Fahn
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Neurodegeneration and neuroprotection in Parkinson diseaseStanley Fahn, David Sulzer
Movement Disorders : Official Journal of the Movement Disorder Society|October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
"Psychogenic movement disorders": they are what they areStanley Fahn, C Warren Olanow
Current Neurology and Neuroscience Reports|June 5, 2012
Botulinum toxin for the treatment of movement disordersMary Ann Thenganatt, Stanley Fahn
Neurology|April 6, 2016
Levodopa therapy for Parkinson disease: A look backward and forwardPeter A LeWitt, Stanley Fahn
Neurosurgical Focus|March 17, 2005
Status of fetal tissue transplantation for the treatment of advanced Parkinson diseasePaul E Greene, Stanley Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
Frontiers of science and clinical advances in quality of life in Parkinson's disease. PrefaceStanley Fahn, Karen Marder, Lucien Côté
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Translation of Oppenheim's 1911 paper on dystoniaChristine Klein, Stanley Fahn
Cold Spring Harbor Perspectives in Medicine|September 22, 2025
Parkinson's Disease, Second EditionSerge Przedborski, Stanley Fahn
The Journal of Neuropsychiatry and Clinical Neurosciences|November 12, 2002
Methylphenidate treats apathy in Parkinson's diseaseAnjan Chatterjee, Stanley Fahn
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Neurodegeneration and neuroprotection in Parkinson diseaseStanley Fahn, David Sulzer
Movement Disorders : Official Journal of the Movement Disorder Society|October 14, 2014
Reply to: psychogenic movement disorders: what's in a name?Stanley Fahn, C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
"Psychogenic movement disorders": they are what they areStanley Fahn, C Warren Olanow
Current Neurology and Neuroscience Reports|June 5, 2012
Botulinum toxin for the treatment of movement disordersMary Ann Thenganatt, Stanley Fahn
Neurology|April 6, 2016
Levodopa therapy for Parkinson disease: A look backward and forwardPeter A LeWitt, Stanley Fahn
Neurosurgical Focus|March 17, 2005
Status of fetal tissue transplantation for the treatment of advanced Parkinson diseasePaul E Greene, Stanley Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2010
Frontiers of science and clinical advances in quality of life in Parkinson's disease. PrefaceStanley Fahn, Karen Marder, Lucien Côté
Pageof 17